Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06329622 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Jun 30, 2026 → Jun 30, 2028
See other at-risk trials from Huashan Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 30, 2026 to Jun 30, 2028v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Eligibility criteria shortened, about 7 words
    • Study site revised
    v3
  3. Start date: Apr 1, 2024 to May 1, 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that Ketosteril can improve sarcopenia in patients with renal disease without increasing the burden on the kidneys and causing deterioration of renal function. Therefore, this study intends to take patients with CKD stage 3-4 and sarcopenia as the research object, give Ketosteril intervention or not to patients on the base of low-protein diet, and clarify the clinical benefits of Ketosteril prescription for improving sarcopenia in patients with CKD.
Trial Details
NCT Number NCT06329622
Lead Sponsor Huashan Hospital
Conditions
(from sponsor)		 Chronic Kidney Disease, Sarcopenia
Related terms Renal Insufficiency, Chronic, Sarcopenia
Enrollment 58 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov